Novavax
NVAX
#5751
Rank
ยฃ0.84 B
Marketcap
ยฃ5.19
Share price
0.73%
Change (1 day)
-20.26%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.18 Billion

According to Novavax's latest financial reports the company's total debt is ยฃ0.18 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ0.18 B2.11%
2023-12-31ยฃ0.17 B-60.43%
2022-12-31ยฃ0.45 B35.12%
2021-12-31ยฃ0.33 B-2.04%
2020-12-31ยฃ0.34 B39.87%
2019-12-31ยฃ0.24 B-2.38%
2018-12-31ยฃ0.25 B6.95%
2017-12-31ยฃ0.23 B-8.29%
2016-12-31ยฃ0.25 B96083.1%
2015-12-31ยฃ0.26 M-58.42%
2014-12-31ยฃ0.64 M-43.79%
2013-12-31ยฃ1.14 M52.96%
2012-12-31ยฃ0.74 M262.12%
2011-12-31ยฃ0.2 M-20.54%
2010-12-31ยฃ0.25 M-13.72%
2009-12-31ยฃ0.3 M-98.08%
2008-12-31ยฃ15.63 M36.5%
2007-12-31ยฃ11.45 M-3.27%
2006-12-31ยฃ11.83 M-33.13%
2005-12-31ยฃ17.7 M-8.54%
2004-12-31ยฃ19.35 M-17.87%
2003-12-31ยฃ23.57 M-8.72%
2002-12-31ยฃ25.82 M9.04%
2001-12-31ยฃ23.68 M76.73%
2000-12-31ยฃ13.4 M21552.36%
1999-12-31ยฃ0.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
ยฃ34.35 M-81.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ0.93 B 397.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.49 B 164.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.48 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ24.49 B 12,893.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ45.67 B 24,128.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ24.03 B 12,650.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
ยฃ1.12 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ17.91 B 9,401.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
ยฃ1.96 M-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA